Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review
2024

Traditional Chinese Medicine for COVID-19 with Comorbidities: A Scoping Review

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): Shang Xiyu, Cao Yuqing, Guo Yang, Zhang Lei, Li Jiajia, Zhang Huifang, Fan Yipin, Huang Yuxuan, Li Jiantao, Wang Yanping, Xiong Yibai

Primary Institution: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China

Hypothesis

What is the efficacy of Traditional Chinese Medicine (TCM) in treating COVID-19 patients with comorbidities?

Conclusion

TCM has shown significant potential in improving clinical symptoms and outcomes for COVID-19 patients with comorbidities.

Supporting Evidence

  • TCM has significantly improved clinical symptoms such as fever, fatigue, and dry cough in COVID-19 patients with comorbidities.
  • Existing studies indicate that TCM can shorten the duration of viral shedding and the course of disease.
  • Research focused on circulatory diseases, endocrine and metabolic diseases, and respiratory diseases among COVID-19 patients.

Takeaway

This study looks at how traditional Chinese medicine can help people with COVID-19 who also have other health problems. It found that TCM can make them feel better.

Methodology

The review involved searching multiple databases for relevant literature on TCM treatments for COVID-19 with comorbidities from January 2020 to January 2024.

Potential Biases

Most studies included were observational, which may introduce bias in the results.

Limitations

The review is limited by the inclusion of only studies published in English and Chinese, potentially introducing language bias.

Digital Object Identifier (DOI)

10.1186/s40249-024-01263-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication